Overview

A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126)

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate and evaluate the efficacy of Eszopiclone in Japanese participants with primary insomnia.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Eisai Co., Ltd.
Treatments:
Eszopiclone
Zolpidem